SCHEMBL824856

SCHEMBL824856

CC(C)(C)OC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(OC(C)(C)C)C(O)C3O)C(O)C2O)C(O)C1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MAPT P10636 1/20 0.47
▸ AMY1A P0DUB6 2/20 0.46
▸ LGALS8 O00214 1/20 0.46
▸ LGALS3 P17931 1/20 0.46
▸ LGALS4 P56470 1/20 0.46
▸ AMY2A P04746 2/20 0.43
▸ TYR P14679 6/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GAA P10253 4/20 0.39
▸ MGAM O43451 2/20 0.39
▸ SI P14410 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24004413 0.94 L3MBTL1 (0.53) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL13034058 0.94 L3MBTL1 (0.53) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL24004411 0.94 L3MBTL1 (0.53) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL26211402 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL26211383 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL26211411 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL18608056 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL26211750 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL20998700 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3
SCHEMBL26211387 0.92 L3MBTL1 (0.57) L3MBTL1MAPTAMY1ALGALS8LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9968905-B2 Processing biomass XYLECO, INC. (US) 2018-05-15 — — US disclosed
US-20160167010-A1 PROCESSING BIOMASS XYLECO, INC. 2016-06-16 — — US disclosed
US-20160090614-A1 PROCESSING BIOMASS XYLECO, INC. 2016-03-31 — — US disclosed
US-9278896-B1 Processing biomass XYLECO, INC. (US) 2016-03-08 — — US disclosed
US-20150344914-A1 PROCESSING BIOMASS XYLECO, INC. 2015-12-03 — — US disclosed
US-9187769-B1 Processing biomass XYLECO, INC. (US) 2015-11-17 — — US disclosed
US-20150265997-A1 PROCESSING BIOMASS XYLECO, INC. 2015-09-24 — — US disclosed
US-9132407-B1 Processing biomass XYLECO, INC. (US) 2015-09-15 — — US disclosed
US-9062328-B2 Processing biomass XYLECO, INC. (US) 2015-06-23 — — US disclosed
US-20150104843-A1 PROCESSING BIOMASS XYLECO, INC. 2015-04-16 — — US disclosed
US-8716537-B2 Processing biomass XYLECO, INC. (US) 2014-05-06 — — US disclosed
US-8497366-B2 Processing biomass XYLECO, INC. (US) 2013-07-30 — — US disclosed
US-20130102029-A1 Processing Biomass XYLECO, INC. (US) 2013-04-25 — — US disclosed
US-8212087-B2 Processing biomass XYLECO, INC. (US) 2012-07-03 — — US disclosed
US-8142620-B2 Processing biomass XYLECO, INC. (US) 2012-03-27 — — US disclosed
US-8083906-B2 Processing biomass XYLECO, INC. (US) 2011-12-27 — — US disclosed
US-20110111456-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2011-05-12 — — US disclosed
US-20100304439-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2010-12-02 — — US disclosed
US-20100179315-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2010-07-15 — — US disclosed
US-20100087687-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2010-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087687-A1 PROCESSING BIOMASS GYS2, GYS1, MGAM L3MBTL1 2140/4885MAPT 677/4885AMY1A 16/4885
US-20100179315-A1 PROCESSING BIOMASS GYS2, GYS1, MGAM L3MBTL1 2140/4885MAPT 677/4885AMY1A 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback